GLB-002 | m-entrepreneurship.com

Product Name :
GLB-002

Search keywords :
Ikaros

drugId :
null

Target Vo:
DNA-binding protein Ikaros

Target Vo Short Name :
IKZF1

Moa_Name:
DNA-binding protein Ikaros degraders

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
GluBio Therapeutics Inc

Active Company_Name :
Hangzhou GluBio Pharmaceutical Co Ltd

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Synaptophysin Antibody (YA664)
ASC Antibody
GABARAP Antibody: GABARAP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to GABARAP. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts